Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind study.

Carolina de Meneses-GayaJosé Alexandre de Souza CrippaJaime E HallakAndré de Queiroz Constantino MiguelRonaldo LaranjeiraRodrigo A BressanAntonio W ZuardiAcioly L Lacerda

Published in: Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) (2021)

Under the conditions of this trial, CBD was unable to interfere with symptoms of crack-cocaine withdrawal. Further studies with larger outpatient samples involving different doses and treatment periods would be desirable and timely to elucidate the potential of CBD to induce reductions in crack-cocaine self-administration.

Keyphrases

clinical trial
study protocol
phase iii
randomized controlled trial
phase ii
risk assessment
human health